| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Vitamin D3 | Cystic Fibrosis | 7 | PM | 34815946 | 📋 | A Clinician's guide to vitamin D supplementation for patients with cystic fibrosis |
| Vitamin D3 | Cystic Fibrosis | 5 | PM | 30922377 | 📋 | Vitamin D inhibits pro-inflammatory cytokines in the airways of cystic fibrosis patients infected by Pseudomonas aeruginosa- pilot study |
| Vitamin D3 | Cystic Fibrosis | 1 | PM | 29161417 | 📋 | Bolus Weekly Vitamin D3 Supplementation Impacts Gut and Airway Microbiota in Adults With Cystic Fibrosis: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial |
| Vitamin D3 | Cystic Fibrosis | 3 | PM | 28403943 | 📋 | Plasma metabolomics in adults with cystic fibrosis during a pulmonary exacerbation: A pilot randomized study of high-dose vitamin D 3 administration |
| Vitamin D3 | Cystic Fibrosis | 6 | PM | 27966575 | 📋 | Clinical impact of vitamin D treatment in cystic fibrosis: a pilot randomized, controlled trial |
| Vitamin D3 | Cystic Fibrosis | 2 | PM | 27011794 | 📋 | Vitamin D supplementation decreases Aspergillus fumigatus specific Th2 responses in CF patients with aspergillus sensitization: a phase one open-label study |
| Vitamin D3 | Cystic Fibrosis | 4 | PM | 19447079 | 📋 | Very high-dose ergocalciferol is effective for correcting vitamin D deficiency in children and young adults with cystic fibrosis |
| Vitamin D3 | Fibrosis | 1 | PM | 34251424 | 📋 | Effect of Vitamin D3 on Regulating Human Tenon's Fibroblasts Activity |
| Vitamin D3 | Hepatic Fibrosis | 14 | PM | 38413933 | 📋 | Effects of vitamin D supplementation on liver fibrogenic factors, vitamin D receptor and liver fibrogenic microRNAs in metabolic dysfunction-associated steatotic liver disease (MASLD) patients: an exploratory randomized clinical trial |
| Vitamin D3 | Hepatic Fibrosis | 13 | PM | 37274069 | 📋 | Calcitriol attenuates liver fibrosis through hepatitis C virus nonstructural protein 3-transactivated protein 1-mediated TGF β1/Smad3 and NF-κB signaling pathways |
| Vitamin D3 | Hepatic Fibrosis | 12 | PM | 36815587 | 📋 | Low 25 (OH) vitamin D levels are associated with increased prevalence of NAFLD and significant liver fibrosis |
| Vitamin D3 | Hepatic Fibrosis | 11 | PM | 36539869 | 📋 | [Protective effect of active vitamin D on liver fibrosis induced by sodium arsenite in SD rats] |
| Vitamin D3 | Hepatic Fibrosis | 10 | PM | 36145170 | 📋 | Combination Treatment with Hydroxytyrosol and Vitamin E Improves NAFLD-Related Fibrosis |
| Vitamin D3 | Hepatic Fibrosis | 9 | PM | 35849204 | 📋 | Combined resveratrol and vitamin D treatment ameliorate inflammation-related liver fibrosis, ER stress, and apoptosis in a high-fructose diet/streptozotocin-induced T2DM model |
| Vitamin D3 | Hepatic Fibrosis | 2 | PM | 35043727 | 📋 | Calcipotriol attenuates liver fibrosis through the inhibition of vitamin D receptor-mediated NF-κB signaling pathway |
| Vitamin D3 | Hepatic Fibrosis | 7 | PM | 33309619 | 📋 | Vitamin D alleviates liver fibrosis by inhibiting histidine-rich calcium binding protein (HRC) |
| Vitamin D3 | Hepatic Fibrosis | 8 | PM | 32742635 | 📋 | Pharmaceutic application of vitamin D 3 on particle-induced fibrotic effects through induction of Nrf2 signals |
| Vitamin D3 | Hepatic Fibrosis | 5 | PM | 30825110 | 📋 | Antifibrotic Effects of 1,25(OH) 2 D 3 on Nonalcoholic Steatohepatitis in Female Mice |
| Vitamin D3 | Hepatic Fibrosis | 1 | PM | 30271082 | 📋 | Mechanism of Combined Use of Vitamin D and Puerarin in Anti-Hepatic Fibrosis by Regulating the Wnt/β-catenin Signalling Pathway |
| Vitamin D3 | Hepatic Fibrosis | 4 | PM | 28809744 | 📋 | Effect of Vitamin D Serum Levels and GC Gene Polymorphisms in Liver Fibrosis Due to Chronic Hepatitis C |
| Vitamin D3 | Hepatic Fibrosis | 6 | PM | 27578035 | 📋 | Vitamin D Attenuates Kidney Fibrosis via Reducing Fibroblast Expansion, Inflammation, and Epithelial Cell Apoptosis |
| Vitamin D3 | Hepatic Fibrosis | 3 | PM | 26121590 | 📋 | Low 25-Hydroxyvitamin D Levels Are Associated with Infections and Mortality in Patients with Cirrhosis |
| Vitamin D3 | Kidney Fibrosis | 2 | PM | 34147475 | 📋 | High-dose vitamin D3 c ameliorates renal fibrosis by vitamin D receptor activation and inhibiting TGF-β1/Smad3 signaling pathway in 5/6 nephrectomized rats |
| Vitamin D3 | Kidney Fibrosis | 1 | PM | 33530801 | 📋 | 1,25-(OH) 2 D 3 ameliorates renal interstitial fibrosis in UUO rats through the AMPKα/mTOR pathway |
| Vitamin D3 | Myocardial Fibrosis | 2 | PM | 37654818 | 📋 | The effects of vitamin D on cardiovascular damage induced by lipopolysaccharides in rats |
| Vitamin D3 | Myocardial Fibrosis | 1 | PM | 33428175 | 📋 | Concurrent vitamin D supplementation and exercise training improve cardiac fibrosis via TGF-β/Smad signaling in myocardial infarction model of rats |
| Vitamin D3 | Pulmonary Fibrosis | 4 | PM | 38185349 | 📋 | Antifibrotic effects of vitamin D3 on human lung fibroblasts derived from patients with idiopathic pulmonary fibrosis |
| Vitamin D3 | Pulmonary Fibrosis | 3 | PM | 35623829 | 📋 | Effects of supplementation of vitamins D, C and E on Idiopathic Pulmonary Fibrosis (IPF): A clinical trial |
| Vitamin D3 | Pulmonary Fibrosis | 2 | PM | 34656907 | 📋 | Vitamin D3 alleviates pulmonary fibrosis by regulating the MAPK pathway via targeting PSAT1 expression in vivo and in vitro |
| Vitamin D3 | Pulmonary Fibrosis | 1 | PM | 30659895 | 📋 | Vitamin D prevents experimental lung fibrosis and predicts survival in patients with idiopathic pulmonary fibrosis |
